AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status

Rui Ma(First Hospital of China Medical University), Yunpeng Liu(First Hospital of China Medical University)
British Journal of Cancer
May 10, 2018
Cited by 29


Related Papers